4th Quarter - Termination

ARENTFOX SCHIFF LLP for SANOFI PASTEUR

Firm
Client
Income
$20,000
Expenses
—
Terminated
Dec 31, 2009

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Swine flu vaccine Childhood immunizations Flu vaccine and miscellaneous vaccination issues

Foreign entity interest: Sanofi-aventis Group, identified in a 7/15/05 information update to the LD-1, is interested in U.S. vaccination policies that may affect the business of its subsidiary sanofi pasteur.

LobbyistCovered position, as disclosed
DALE BUMPERS —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.